Management of Herpes: Contagiousness and Treatment Plan
Herpes is highly contagious through direct contact with lesions and can be transmitted even during asymptomatic periods, requiring antiviral therapy either as episodic or suppressive treatment based on frequency and severity of outbreaks. 1
Contagiousness of Herpes
Herpes is a highly contagious viral infection that can be transmitted in several ways:
- Direct contact with active lesions during symptomatic periods
- Asymptomatic viral shedding (transmission without visible symptoms)
- Sexual contact when no visible lesions are present 1
Key points about transmission:
- Genital herpes is frequently transmitted in the absence of symptoms through asymptomatic viral shedding 2, 3
- Patients should abstain from sexual activity while lesions are present 1
- Condom use should be encouraged during all sexual exposures 1
- Even with suppressive therapy, transmission risk is not completely eliminated 1
Treatment Approaches
1. Episodic Therapy (for individual outbreaks)
For genital herpes outbreaks:
- Acyclovir 200 mg orally 5 times daily for 5 days OR
- Acyclovir 400 mg orally 3 times daily for 5 days OR
- Acyclovir 800 mg orally 2 times daily for 5 days 1
Alternative options:
Treatment should be initiated at the first sign or symptom of an episode for maximum effectiveness 1, 2, 3
2. Suppressive Therapy (for frequent recurrences)
For patients with 6 or more recurrences per year:
Benefits of suppressive therapy:
- Reduces frequency of HSV recurrences by at least 75% 1
- Decreases severity and duration of breakthrough episodes 4
- Reduces asymptomatic viral shedding 4
- May help prevent transmission to sexual partners 1
3. Severe Disease Management
For severe or disseminated infection requiring hospitalization:
- Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution 1
Special Considerations
Treatment Duration and Assessment
- After 1 year of continuous suppressive therapy, acyclovir should be discontinued to reassess the patient's rate of recurrent episodes 1
- No data on safety or effectiveness of chronic suppressive therapy beyond 1 year in immunocompetent patients 3
Acyclovir-Resistant Herpes
- Case reports suggest brincidofovir, imiquimod, and topical cidofovir may be useful for acyclovir-resistant infections 1
- Foscarnet is the main alternative with proven efficacy for resistant strains 5
Patient Education
Patients should be advised that:
- Herpes is not curable but manageable with treatment 2, 3
- Treatment reduces symptoms and improves quality of life but doesn't eliminate the virus 6
- They should initiate treatment at the earliest sign of recurrence 2, 3
- Risk of neonatal infection should be explained to all patients 1
Treatment Algorithm
Diagnosis confirmation: Clinical assessment or laboratory testing (HSV-2 serologic testing for those with genital symptoms) 1
Determine treatment approach:
- First episode: Use episodic therapy at higher doses
- Recurrent episodes (≤6 per year): Episodic therapy
- Frequent recurrences (>6 per year): Consider suppressive therapy
- Severe disease: IV therapy
Monitor and adjust:
- Assess treatment response
- Consider discontinuing suppressive therapy after 1 year to reassess recurrence frequency
- Watch for treatment resistance, especially in immunocompromised patients
Common Pitfalls to Avoid
- Delaying treatment beyond 72 hours of symptom onset significantly reduces effectiveness 1, 3
- Failing to counsel patients about asymptomatic viral shedding and transmission risk 1
- Not adjusting dosage for patients with renal impairment 4
- Overlooking the psychological impact of herpes diagnosis and recurrences 7, 8
- Assuming suppressive therapy completely eliminates transmission risk 1
Remember that while treatment significantly improves symptoms and quality of life, herpes remains a chronic, lifelong infection requiring ongoing management 6, 8.